APA (7th ed.) Citation

Tuffaha, M., Hananeh, W., Bangemann, N., Tuffaha, A., & Starke, M. (2026). Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides. Biomolecules (2218-273X), 16(5), 706. https://doi.org/10.3390/biom16050706

Chicago Style (17th ed.) Citation

Tuffaha, Muin, Wael Hananeh, Nikola Bangemann, Amro Tuffaha, and Michael Starke. "Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides." Biomolecules (2218-273X) 16, no. 5 (2026): 706. https://doi.org/10.3390/biom16050706.

MLA (9th ed.) Citation

Tuffaha, Muin, et al. "Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides." Biomolecules (2218-273X), vol. 16, no. 5, 2026, p. 706, https://doi.org/10.3390/biom16050706.